Phase 1 study of ALK001 for stargardt disease

Ended Cooperative Agreement Awarded Last action

Award ID
R01FD004098
Recipient
Awarding agency
Obligated
$415,984

Award facts

Assistance listing
93.103 Food and Drug Administration Research
Completion date
Originally
Funding agency
Department of Health and Human Services
Place of performance
Cambridge, MA 02140, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment $249,112
Amendment ALK-001 phase 2 treatment of stargardt disease IND 108,353 (09/08/2015) -$1
Original award $166,873

Quick answers

Who received award R01FD004098?

R01FD004098 was awarded to Alkeus Pharmaceuticals Inc. by Food and Drug Administration (Department of Health and Human Services) on September 1, 2013.

How much is award R01FD004098 worth?

$415,984 has been obligated on R01FD004098.

Which agency awarded R01FD004098?

Food and Drug Administration (Department of Health and Human Services) awarded R01FD004098, with funding from Department of Health and Human Services.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award